Products

What will AGI do for Aminophenazone or aminopyrine?

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C13H17N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 01704YP3MO, chemically known as 1,5-dimethyl-2-phenyl-4-aminopyrazoline but generally known as aminophenazone, which bears US NIH Compound Identifier 2151. Aminophenazone most often comes in base, 2,5-dihydroxybenzoate, cyclamate, and salicylate forms. European Medicines Agency schedules Aminophenazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05442MIG. The term AMINOPHENAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 19 1975, List 5). World Health Organization schedules aminophenazone in its Anatomical Therapeutic Chemical (ATC) Classification. AMINOPHENAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Aminophenazone or aminopyrine bears US NLM identifiers UMLS ID C0002586 and NCI Concept Code C76792. SMILES: O=C1N(N(C(C1N)C)C)C1CCCCC1.